Opportunity ID: 282326

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-FD-16-015
Funding Opportunity Title: Architectural review of the BRIDG model (U01)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Consumer Protection
Food and Nutrition
Health
Category Explanation:
Expected Number of Awards: 1
Assistance Listings: 93.103 — Food and Drug Administration_Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Mar 17, 2016
Last Updated Date:
Original Closing Date for Applications: May 23, 2016
Current Closing Date for Applications: May 23, 2016
Archive Date: Jun 22, 2016
Estimated Total Program Funding: $225,000
Award Ceiling: $225,000
Award Floor:

Eligibility

Eligible Applicants: Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
County governments
For profit organizations other than small businesses
Native American tribal governments (Federally recognized)
Small businesses
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
City or township governments
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
Public and State controlled institutions of higher education
Private institutions of higher education
State governments
Special district governments
Independent school districts
Additional Information on Eligibility: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the HHS Grants Policy Statement, are not allowed.

Additional Information

Agency Name: Food and Drug Administration
Description: The Biomedical Research Integrated Domain Group (BRIDG) project is a collaborative effort engaging stakeholders from Clinical Data Interchange Standards Consortium (CDISC), US Food and Drug Administration (FDA), HL7 Regulated Clinical Research Information Management (HL7 RCRIM) Work Group, and US National Cancer Institute (NCI). The goal of BRIDG is to produce a shared view of the domain of protocol-driven research with its associated regulatory artifacts, as well as the basic life sciences research. As the model has evolved over years to meet the needs of multiple stakeholders, CDER is interested in conducting an architectural review of BRIDG, to ensure it is optimized to meet the key objectives of long-term sustainability and interoperability with the healthcare domain.
Link to Additional Information: full announcement of RFA-FD-16-015
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Eric Bozoian

Grants Management Specialist

Phone 2404027623
Email:Eric.Bozoian@fda.hhs.gov

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: Eric Bozoian
Grants Management Specialist
Phone 2404027623
Email: Eric.Bozoian@fda.hhs.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
93.103 PKG00221702 Mar 24, 2016 May 23, 2016 View

Package 1

Mandatory forms

282326 RR_SF424_2_0-2.0.pdf

282326 PHS398_CoverPageSupplement_3_0-3.0.pdf

282326 RR_OtherProjectInfo_1_3-1.3.pdf

282326 PerformanceSite_2_0-2.0.pdf

282326 RR_KeyPersonExpanded_2_0-2.0.pdf

282326 RR_Budget_1_3-1.3.pdf

282326 PHS398_ResearchPlan_3_0-3.0.pdf

Optional forms

282326 RR_SubawardBudget30_1_3-1.3.pdf

282326 PHS_Inclusion_Enrollment_Report-1.0.pdf

282326 PHS_AssignmentRequestForm-1.0.pdf

2025-07-09T10:54:16-05:00

Share This Post, Choose Your Platform!

About the Author: